TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCIF) on Wednesday reported a loss of $2.2 million in its fourth quarter.
On a per-share basis, the Toronto-based company said it had a loss of 69 cents.
The drug developer posted revenue of $1.8 million in the period.
For the year, the company reported a loss of $10.4 million, or $3.27 per share. Revenue was reported as $7.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CSCIF at https://www.zacks.com/ap/CSCIF